The interaction of mofebutazone with furosemide

References

• Abe K., Yasujima M., Chiba S., Irokawa N., Ito T., Yoshinaga K. Effect of furosemide on urinary excretion of prostaglandin E in normal volunteers and patients with essential hypertension. Prostaglandins 1977; 14: 513–5211. Abe K., Yasujima M., Chiba S., Irokawa N., Ito T., Yoshinaga K. Effect of furosemide on urinary excretion of prostaglandin E in normal volunteers and patients with essential hypertension. Prostaglandins 1977; 14: 513–521
   PubMedGoogle Scholar
• Aiken J. W., Vane J. R. Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J. Pharmacol. Exp. Ther 1973; 184: 6782. Aiken J. W., Vane J. R. Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J. Pharmacol. Exp. Ther 1973; 184: 678
   PubMed Web of Science ®Google Scholar
• Anderson R. J., Berl T., McDonald K. M., Schrier R. W. Prostaglandins: effects on blood pressure, renal blood flow, sodium and water excretion. Kidney Int 1976; 10: 205–2153. Anderson R. J., Berl T., McDonald K. M., Schrier R. W. Prostaglandins: effects on blood pressure, renal blood flow, sodium and water excretion. Kidney Int 1976; 10: 205–215
   PubMed Web of Science ®Google Scholar
• Bailie M. C., Crosslan K., Hook J. B. Natriuretic effect of furosemide after inhibition of prostaglandin synthetase. J. Pharmacol. Exp. Ther 1976; 199: 469–4764. Bailie M. C., Crosslan K., Hook J. B. Natriuretic effect of furosemide after inhibition of prostaglandin synthetase. J. Pharmacol. Exp. Ther 1976; 199: 469–476
   PubMed Web of Science ®Google Scholar
• Berg K. J. Acute effects of acetylsalicylic acid on renal function in normal man. Eua. J. Clin. Pharmacol 1977; 11: 117–1235. Berg K. J. Acute effects of acetylsalicylic acid on renal function in normal man. Eua. J. Clin. Pharmacol 1977; 11: 117–123
   PubMed Web of Science ®Google Scholar
• Berg K. J., Bergan A. Effects of different doses of acetylsalicylic acid on renal function in the dog. Scand. J. Clin. Lab. Invest 1976; 36: 779–7866. Berg K. J., Bergan A. Effects of different doses of acetylsalicylic acid on renal function in the dog. Scand. J. Clin. Lab. Invest 1976; 36: 779–786
   PubMed Web of Science ®Google Scholar
• Berg K. J., Loew D. Inhibition of furosemide-induced natriuresis by acetylsalicylic acid in dogs. Scand. J. Clin. Lab. Invest 1977; 37: 125–1317. Berg K. J., Loew D. Inhibition of furosemide-induced natriuresis by acetylsalicylic acid in dogs. Scand. J. Clin. Lab. Invest 1977; 37: 125–131
   PubMed Web of Science ®Google Scholar
• Brater D. C. Analysis of the effect of indomethacin on the response to furosemide in man: effect of dose of furosemide. J. Pharmacol. Exp. Thea 1979; 210: 386–3908. Brater D. C. Analysis of the effect of indomethacin on the response to furosemide in man: effect of dose of furosemide. J. Pharmacol. Exp. Thea 1979; 210: 386–390
   PubMed Web of Science ®Google Scholar
• Clive D. M., Stoff J. S. Renal syndromes associated with non-steroidal anti-inflammatory drugs. N. Engl. J. Med 1984; 310: 563–5729. Clive D. M., Stoff J. S. Renal syndromes associated with non-steroidal anti-inflammatory drugs. N. Engl. J. Med 1984; 310: 563–572
   PubMed Web of Science ®Google Scholar
• Coersmeier C., Wittenberg H. R., Aehringhaus U., Dreyling K. W., Peskar B. M., Brune K., Peskar B. A. Effect of anti-inflammatory and analgesic pyrazoles on arachidonic acid metabolism in isolated heart and gastric mucosa preparations. “100 Jahre Pyrazolone”, K. Brune, et al. Urban & Schwarzenberg, Munich 1985; 010. Coersmeier C., Wittenberg H. R., Aehringhaus U., Dreyling K. W., Peskar B. M., Brune K., Peskar B. A. Effect of anti-inflammatory and analgesic pyrazoles on arachidonic acid metabolism in isolated heart and gastric mucosa preparations. “100 Jahre Pyrazolone”, K. Brune, et al. Urban & Schwarzenberg, Munich 1985; 0
   Google Scholar
• Donker A. J. M., Arzisz L., Brentjens J. R.H., van der Hem G. K., Hollemans H. J. G. The effect of indomethacin on kidney function and plasma renin activity in man. Nephron 1976; 17: 288–29611. Donker A. J. M., Arzisz L., Brentjens J. R.H., van der Hem G. K., Hollemans H. J. G. The effect of indomethacin on kidney function and plasma renin activity in man. Nephron 1976; 17: 288–296
   PubMed Web of Science ®Google Scholar
• Dunn M. J. Non-steroidal anti-inflammatory drugs and renal function. Annu. Rev 1984; Med. 35: 411–42812. Dunn M. J. Non-steroidal anti-inflammatory drugs and renal function. Annu. Rev 1984; Med. 35: 411–428
   PubMed Web of Science ®Google Scholar
• Düsing R., Melder B., Kramer H. J. Prostaglandins and renal function in acute extracellular volume expansion. Prostaglandins 1976; 12: 3–1013. Düsing R., Melder B., Kramer H. J. Prostaglandins and renal function in acute extracellular volume expansion. Prostaglandins 1976; 12: 3–10
   PubMedGoogle Scholar
• Düsing R., Nicolas V., Glatte B., Glänzer K., Kipnowski J., Kramer H. J. Interaction of bemetanide and indomethacin in the kidney. Br. J. Clin. Pharmacol 1983; 16: 377–38414. Düsing R., Nicolas V., Glatte B., Glänzer K., Kipnowski J., Kramer H. J. Interaction of bemetanide and indomethacin in the kidney. Br. J. Clin. Pharmacol 1983; 16: 377–384
   PubMed Web of Science ®Google Scholar
• Frölich J. C., Hollifield J. W., Dormois J. C., Frölich B. L., Seyberth H., Michelakis A. M., Oates J. A. Suppression of plasma renin activity by indomethacin in man. Circ. Res 1976; 39: 447–45215. Frölich J. C., Hollifield J. W., Dormois J. C., Frölich B. L., Seyberth H., Michelakis A. M., Oates J. A. Suppression of plasma renin activity by indomethacin in man. Circ. Res 1976; 39: 447–452
   PubMed Web of Science ®Google Scholar
• Gerber J. G., Data J. L., Nies A. S. Enhanced renal prostaglandin production in the dog. The effect of sodium arachidonate in non-filtering kidney. Circ. Res 1978; 42: 43–4516. Gerber J. G., Data J. L., Nies A. S. Enhanced renal prostaglandin production in the dog. The effect of sodium arachidonate in non-filtering kidney. Circ. Res 1978; 42: 43–45
   PubMed Web of Science ®Google Scholar
• Grizzle J. E. The two-period change-over design and its use in clinical trials. Biometrics 1965; 21: 467–48017. Grizzle J. E. The two-period change-over design and its use in clinical trials. Biometrics 1965; 21: 467–480
   PubMed Web of Science ®Google Scholar
• Kamp J., Loew D., Barkow D., Deister J., Schuster O., Knoell H. E. Zur Kinetik von Mofebutazon im Plasma und in der Synovialflüssigkeit. Z. Rheumatol 1984; 43: 179–18118. Kamp J., Loew D., Barkow D., Deister J., Schuster O., Knoell H. E. Zur Kinetik von Mofebutazon im Plasma und in der Synovialflüssigkeit. Z. Rheumatol 1984; 43: 179–181
   PubMedGoogle Scholar
• Kramer H. J., Düsing R., Stinnesbeck B., Prior W., Bäcker A., Eden J., Kipnowski J, Glänzer K., Krück E. Interaction of conventional and antikaliuretic diuretics with the renal prostaglandin system. Clin. Sci 1980; 59: 67–7019. Kramer H. J., Düsing R., Stinnesbeck B., Prior W., Bäcker A., Eden J., Kipnowski J, Glänzer K., Krück E. Interaction of conventional and antikaliuretic diuretics with the renal prostaglandin system. Clin. Sci 1980; 59: 67–70
   PubMed Web of Science ®Google Scholar
• Landi A. Esperienze cliniche con un nuovo derivato monofenilico del butazone. Ateneo Parmense (Acta Biomed 1959; 30: 815–81920. Landi A. Esperienze cliniche con un nuovo derivato monofenilico del butazone. Ateneo Parmense (Acta Biomed 1959; 30: 815–819
   Google Scholar
• Lanz R., Peskar B. A., Brune K. Wirkung von sauren und nichts-sauren Pyrazolen auf den Arachidonsäurestoffwechsel von Mausperitonealmkrophagen. 100 Jahre Pyrazolone”, K. Brune, et al. Urban & Schwarzenberg, Munich 1985; 021. Lanz R., Peskar B. A., Brune K. Wirkung von sauren und nichts-sauren Pyrazolen auf den Arachidonsäurestoffwechsel von Mausperitonealmkrophagen. 100 Jahre Pyrazolone”, K. Brune, et al. Urban & Schwarzenberg, Munich 1985; 0
   Google Scholar
• Lee J. B., Patak R. V., Mookerjee B. K. Renal prostaglandins and the regulation of blood pressure and sodium and water homeostasis. Am. J. Med 1976; 60: 798–81622. Lee J. B., Patak R. V., Mookerjee B. K. Renal prostaglandins and the regulation of blood pressure and sodium and water homeostasis. Am. J. Med 1976; 60: 798–816
   PubMed Web of Science ®Google Scholar
• hew D., Schuster O., Knoell H. E. Zur Pharmakologie, Toxikologie und Pharmakokinetik von Mofebutazon. Z. Rheumatol 1985; 44: 186–19223. hew D., Schuster O., Knoell H. E. Zur Pharmakologie, Toxikologie und Pharmakokinetik von Mofebutazon. Z. Rheumatol 1985; 44: 186–192
   PubMedGoogle Scholar
• Mrongovius R., Bass V.-M., Schulte K. E. Anti-inflammatory activity and disposition in the rat of mofebutazone and two degradation products. Eur J. Med. Chem 1982; 17: 275–27924. Mrongovius R., Bass V.-M., Schulte K. E. Anti-inflammatory activity and disposition in the rat of mofebutazone and two degradation products. Eur J. Med. Chem 1982; 17: 275–279
   Web of Science ®Google Scholar
• Olsen U. B. Indomethacin inhibition of bumetanide diuresis in dogs. Acta Pharmacol. Toxicol. (Copenh 1975; 37: 65–7825. Olsen U. B. Indomethacin inhibition of bumetanide diuresis in dogs. Acta Pharmacol. Toxicol. (Copenh 1975; 37: 65–78
   PubMedGoogle Scholar
• Patak R. V., Mookerjee B. K., Bemtzel C. J., Hysert P. E., Babej M., Lee J. B. Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins 1975; 10: 649–65926. Patak R. V., Mookerjee B. K., Bemtzel C. J., Hysert P. E., Babej M., Lee J. B. Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins 1975; 10: 649–659
   PubMed Web of Science ®Google Scholar
• Piper P. J., Vane J. R. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature 1969; 223: 29–3527. Piper P. J., Vane J. R. Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs. Nature 1969; 223: 29–35
   PubMed Web of Science ®Google Scholar
• Roquebert M. J., Dumarth A., Courtois P., Quintard B. Comparaison entre quelques propriétes pharmacodynamiques de la monophéylbutazone et de la diphényl-butazone. Bull. Soc. Pharm. Bordeaux 1966; 105: 145–15128. Roquebert M. J., Dumarth A., Courtois P., Quintard B. Comparaison entre quelques propriétes pharmacodynamiques de la monophéylbutazone et de la diphényl-butazone. Bull. Soc. Pharm. Bordeaux 1966; 105: 145–151
   Google Scholar
• Schoetensack W. über Parazolidine und ihre pharmakologische Differenzierung. Arch. Exp. Path. Pharmakol 1958; 233: 365–37529. Schoetensack W. über Parazolidine und ihre pharmakologische Differenzierung. Arch. Exp. Path. Pharmakol 1958; 233: 365–375
   PubMedGoogle Scholar
• Schönhöfer P. S. Interaktionen antirheumatisch wirksamer Substanzen. Internist 1979; 20: 433–43830. Schönhöfer P. S. Interaktionen antirheumatisch wirksamer Substanzen. Internist 1979; 20: 433–438
   PubMedGoogle Scholar
• Schönhöfer P. S. Wirkungsweise der Antirheumatika aus der Sicht des klinischen Pharmakologen. Therapiewoche 1981; 31: 2099–211131. Schönhöfer P. S. Wirkungsweise der Antirheumatika aus der Sicht des klinischen Pharmakologen. Therapiewoche 1981; 31: 2099–2111
   Google Scholar
• Schönhöfer P. S., Rücker W. Wirkungsweise nicht-steroidaler Antirheumatika. Therapiewoche 1979; 29: 3954–396832. Schönhöfer P. S., Rücker W. Wirkungsweise nicht-steroidaler Antirheumatika. Therapiewoche 1979; 29: 3954–3968
   Google Scholar
• Schroer K. “Prostaglandine und verwandte Verbindungen”. 0 0, Stuttgart Thieme. New York. 1983; 033. Schroer K. “Prostaglandine und verwandte Verbindungen”. 0 0, Stuttgart Thieme. New York. 1983; 0
   Google Scholar
• Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol 1971; 231: 231–23534. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biol 1971; 231: 231–235
   Web of Science ®Google Scholar
• Wegmüller E. Nicht-steroidale Antirheumatika und Nephrotoxizität. Dtsch. Med. Wochenschr 1985; 110: 469–47235. Wegmüller E. Nicht-steroidale Antirheumatika und Nephrotoxizität. Dtsch. Med. Wochenschr 1985; 110: 469–472
   PubMedGoogle Scholar